person

Rafael Octavio Stryjer, MD

Rafael Stryjer, MD
as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Principal Investigator
KOL signal score 5
0 publications · 0 high-value
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Beer-Yaacov MHC
Roles
Principal Investigator
KOL signal
5
Publications
0 (0 high-value)
Trial investigator
yes

Trials led

2
Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia
NCT02907437Phase 3Unknown
Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study
NCT00708396Phase 4Unknown

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR
Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia
trial
Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study
trial